Stocklytics Platform
Asset logo for symbol EW
Edwards Lifesciences
EW67
$73.80arrow_drop_up4.06%$2.87
S&P500
Asset logo for symbol EW
EW67

$73.80

arrow_drop_up4.06%

Analyst Forecast

Period: Next 12 Months

Analyst Ratings

Edwards Lifesciences (EW) Stocklytics Forecast

Edwards Lifesciences Corp (EW) is a leading medical technology company that specializes in heart valve therapies and critical care monitoring. With a strong track record of innovation and a commitment to improving patient outcomes, Edwards Lifesciences Corp has positioned itself as a key player in the healthcare industry. As investors contemplate the future trajectory of EW's stock price, it's important to consider various factors that could influence its performance.
One key consideration is the company's continued focus on research and development. Edwards Lifesciences Corp invests heavily in developing cutting-edge products and technologies that address unmet medical needs. This commitment to innovation has allowed the company to consistently introduce new and improved products to the market, which can contribute to revenue growth and, consequently, an increase in the stock price. Additionally, the company's strong intellectual property portfolio provides a competitive advantage and serves as a barrier to entry for potential competitors.
add Edwards Lifesciences to watchlist

Keep an eye on Edwards Lifesciences

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Edwards Lifesciences (EW) stock?

Analysts have set a target price of $91.46 for Edwards Lifesciences (EW), based on forecasts from 26 analysts. The predicted price range extends from a high of $107 to a low of $57. This represents a potential increase of up to 44.98% and a decrease of -22.77% from the current price of $73.81. These forecasts are as of 2023 Oct 26.
help

What are the analyst ratings for Edwards Lifesciences (EW) stock?

The analyst ratings for Edwards Lifesciences (EW) are distributed as follows: 13 analysts recommend buying, 19 have a neutral stance, and 0 suggest selling. The prevailing sentiment among the total of 32 analysts leans towards a neutral rating. These ratings indicate the general sentiment among the analysts covering Edwards Lifesciences.
help

What is the AI price prediction for Edwards Lifesciences (EW) stock?

At present, there is no AI or machine-learning-based price prediction available for Edwards Lifesciences (EW) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level